跳至主要内容
临床试验/NCT02212236
NCT02212236已完成2 期

Development and Evaluation of a Psychological Intervention to Alleviate Distress During Haematopoietic Stem-cell Transplantation

University of Nottingham4 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
45
试验地点
4
主要终点
Depression Anxiety Stress Scales (DASS-21)

研究概览

简要总结

This Phase II trial aims to evaluate a new psychological intervention to alleviate distress during haematopoietic stem cell transplantation (HSCT) together with examining feasibility.

HSCT is a complex procedure aimed at a range of haematological and autoimmune illnesses. Over 3,000 individuals undergo the procedure every year in the UK with substantial benefits. However, it is very costly, intensive, and has a range of debilitating side effects. Consequently, patients often experience considerable distress, which can impede recovery.

A 90-minute, group-based intervention has been developed to address this need based on psychological theory of adjustment to illness-related difficulties. It is delivered by the transplant team and involves provision of information to foster more helpful perceptions about HSCT and facilitating more helpful coping with its difficulties. To evaluate the effectiveness of the intervention in alleviating distress, 60 patients about to undergo HSCT at two sites (Sheffield & Nottingham) will be randomly allocated into two groups. Patients in the intervention group will receive the new intervention prior to transplantation together with treatment as usual (TAU) while patients in the control group will receive TAU alone. Participants and the researcher collecting the data will be blind to the allocation.

Demographic and relevant clinical information will be recorded at the end of participation to ensure effectiveness of randomisation. For both groups, resilience, distress, coping, and procedure-related perceptions will be measured at four time points: (i) prior to the intervention/transplantation, (ii) day of transplant, (iii) two weeks following the transplant, and (iv) four weeks following the transplant. It is hypothesised that patients in the intervention group will experience higher resilience and lower distress compared to controls and that this difference will be mediated by procedure-related perceptions and coping. A subgroup of participants of those randomised to the group intervention will be invited to participate in a feedback interview at the end.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients referred for HSCT as treatment for haematological malignancy
  • age of 18 years or older
  • sufficient command of the English language or access to suitable support to comprehend materials and participate in the group and data collection over the telephone
  • informed consent
  • permission will also be sought by the patient's Consultant Haematologist once clients have consented

排除标准

  • Consent withdrawn
  • Consultant Haematologist raises concern regarding participation

结局指标

主要结局

Depression Anxiety Stress Scales (DASS-21)

时间窗: Day 28

Assesses presence of depression, anxiety, stress, and overall distress; 21 items, Likert-type.

次要结局

  • Brief Resilience Scale (BRS)(Day 28)
  • Brief Coping with Problems Experienced scale (COPE)(Day 28)
  • Brief Illness Perceptions Questionnaire (IPQ)(Day 28)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验